Borie, Raphael http://orcid.org/0000-0002-9906-0024
Kannengiesser, Caroline
Gouya, Laurent
Dupin, Clairelyne
Amselem, Serge
Ba, Ibrahima
Bunel, Vincent
Bonniaud, Philippe
Bouvry, Diane
Cazes, Aurélie
Clement, Annick
Debray, Marie Pierre
Dieude, Philippe
Epaud, Ralph
Fanen, Pascale
Lainey, Elodie
Legendre, Marie
Plessier, Aurélie
Sicre de Fontbrune, Flore
Wemeau-Stervinou, Lidwine
Cottin, Vincent
Nathan, Nadia
Crestani, Bruno
Funding for this research was provided by:
Fondation du Souffle (src2015)
Article History
Received: 19 August 2019
Accepted: 19 November 2019
First Online: 3 December 2019
Ethics approval and consent to participate
: All patients signed informed consent for genetic analysis, including for research purposes. The clinical charts of the patients were collected on a standardized and anonymous form. This study was approved by the local ethics committee (CPP Ile de France 1, no. 0811760).
: All patients signed informed consent for publication.
: Dr. Borie reports personal fees and non-financial support from Roche, personal fees and non-financial support from Boerhinger Ingelheim, outside the submitted work. Dr. Debray reports personal fees and non-financial support from Boehringer-Ingelheim, personal fees and non-financial support from Roche, outside the submitted work. Dr. Bonniaud reports personal fees and other fees from Roche, personal fees and other fees from Boehringer, personal fees and other fees from Novartis, personal fees from TEVA, other fees from Chiesi, personal fees from AstraZeneca, other fees from Stallergene, outside the submitted work. Dr. Dupin reports personal fees, non-financial support and other fees from Astra-Zeneca; personal fees, non-financial support and other fees from Boehringer; personal fees, non-financial support and other fees from GSK; personal fees and other fees from Chiesi; personal fees from Sanofi; personal fees, non-financial support and other fees from Novartis; non-financial support and other fees from Roche, outside the submitted work. Dr. Cottin reports personal fees and non-financial support from Actelion; grants, personal fees and non-financial support from Boehringer Ingelheim; personal fees from Bayer/MSD; personal fees from Gilead; personal fees from Novartis; grants, personal fees and non-financial support from Roche; personal fees from Sanofi; personal fees from Promedior; personal fees from Celgene; personal fees from Galapagos; personal fees from Galecto, outside the submitted work. Dr. Crestani reports personal fees from Astra Zeneca; grants, personal fees and non-financial support from Boehringer Ingelheim; grants, personal fees and non-financial support from Roche; personal fees and non-financial support from Sanofi; and grants from Novartis, outside the submitted work.